Personalised telehealth intervention for chronic disease management: A pilot randomised controlled trial.

Source: Bohingamu Mudiy-anselage, S., et al. 2019 - Pubmed ID: 29793387

Setting: Australia, Regional health service center

Study design:



Follow up: 12 months

Patient group:

Sample size:

Total: 177 (163)

IG: 88 (83)

CG: 89(80)


Inclusion criteria:

  • Diabetes and/or chronic obstructive pulmonary disease (COPD)
  • High risk for readmission
Type of technology:

Home monitoring

  • Tablet
  • Peripheral monitoring equipment


  • Health coaching


  • Remote Patient Monitoring from TELUS®

Intervention: Patient collect biometric readings and enter daily answers to health questionnaire. Nurses and specialist consultant provide an individualized care plan with upper and lower limits on individual parameters. Nurses identify when data are outside threshold and respond to pt.


Duration: 12 months

Add on:  NA


Control group: Usual care

Clinical effect/ Patient safety:

Clinical effect:

  • Blood pressure →
  • HbA1c →
  • Total cholesterol →
  • Triglyceride →
  • Microalbumin ↓
  • GAD-7, anxiety↓(improved)
  • PHQ-9 depression ↓(improved)
  • Health literacy domains (HeiQ): 4/8 domains ↑ (improvement)

Patient safety: NA

Patient experiences/ Staff experiences:

Patient experiences: NA


Staff experiences: NA

Costs and organization:



  • Monitoring equipment
  • Remote Patient Monitoring platform from TELUS®


Staff resources

  • Monitoring patient data
  • On call staff
  • Patient coaching sessions


  • Written or telephone contact with primary care (GP)

Health care utilization:

  • Hospital admissions →
  • Mean hospital length of stay → (acute admissions ↓)
  • Mean hospital cost ↓
Scroll to Top


“↑”: Statistically significant increase

“↓”: Statistically significant decrease

“→”: Statistically insignificant (no difference)